Almohanad A. Alkayyal

University of Tabuk — Saudi Arabia

Medicine · Health Sciences

17h-index1.6kcitations74works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer, Stress, Anesthesia, and Immune Response(21), Virus-based gene therapy research(17), Viral Infections and Vectors(14), CAR-T cell therapy research(13), Cancer Immunotherapy and Biomarkers(12)

Publications74 total

Integrated In Silico and In Vivo Evaluation of a Tetravalent SARS-CoV-2 RBD–Fc Fusion Vaccine with Broad Cross-Variant Antibody Responses
Vaccines·2025Open Access
Identification of Small Molecule Inhibitors Targeting PD-L1 Protein Using Computational Tools and an Experimental Assay
Anticancer Research·2025
Immunogenic mutanome of breast cancer: Advances, challenges and future directions in neoantigen-based immunotherapy
Advances in Clinical and Experimental Medicine·2025· 1 citedOpen Access
Insights from veterinary models for advancing oncolytic virotherapy through comparative oncology
Frontiers in Molecular Biosciences·2025Open Access
A 5-Year Update on the Clinical Development of Cancer Cell-Based Vaccines for Glioblastoma Multiforme
Pharmaceuticals·2025· 2 citedOpen Access
Association of iron deficiency anaemia with the hospitalization and mortality rate of patients with COVID‑19
Medicine International·2024· 2 citedOpen Access
Repurposing the oncolytic virus VSV∆51M as a COVID-19 vaccine
Frontiers in Bioengineering and Biotechnology·2023· 1 citedOpen Access
Association of Genetic and Allelic Variants of Von Willebrand Factor (VWF), Glutathione S-Transferase and Tumor Necrosis Factor Alpha with Ischemic Stroke Susceptibility and Progression in the Saudi Population
Life·2023· 6 citedOpen Access
Construction of VSVΔ51M oncolytic virus expressing human interleukin-12
Frontiers in Molecular Biosciences·2023· 10 citedOpen Access
Dihydropyrimidone Derivatives as Thymidine Phosphorylase Inhibitors: Inhibition Kinetics, Cytotoxicity, and Molecular Docking
Molecules·2023· 7 citedOpen Access
Supplementary Fig. S.6 from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
2023Open Access
Supplementary Fig. S.2 from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
2023Open Access
Supplementary Fig. S.1 from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
2023Open Access
Supplementary Fig. S.2 from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
2023Open Access
Supplementary Fig. S.7 from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
2023Open Access
Supplementary Fig. S.4 from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
2023Open Access
Supplementary Fig. S.7 from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
2023Open Access
Supplementary Fig. S.5 from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
2023Open Access
Supplementary figure legends from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
2023Open Access
Supplementary Fig. S.6 from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Ahmad Bakur Mahmoud(27), Lee‐Hwa Tai(25), Christiano Tanese de Souza(24), Rebecca C. Auer(23), Jiqing Zhang(22), John C. Bell(19), Abhirami A. Ananth(18), Shalini Sahi(16), Andrew P. Makrigiannis(14), Anwar M. Hashem(11), David F. Stojdl(11), Charles Lefebvre(10), Michael A. Kennedy(10), Mohamed A. Alfaleh(9), Greg O. Cron(9), Blair Macdonald(9), Abdullah Algaissi(8), Turki S. Abujamel(8), E. Celia Marginean(8), Rowa Y. Alhabbab(7)